Refine
Has Fulltext
- yes (30)
Is part of the Bibliography
- yes (30) (remove)
Year of publication
- 2011 (30) (remove)
Document Type
- Journal article (16)
- Doctoral Thesis (14)
Keywords
- ADHD (4)
- Depression (4)
- fNIRS (4)
- Aufmerksamkeits-Defizit-Syndrom (3)
- depression (3)
- 5-HTT (2)
- 5-HTTLPR (2)
- Alzheimer disease (2)
- Brain-derived neurotrophic factor (2)
- Emotional processing (2)
- Ereigniskorreliertes Potenzial (2)
- Mice (2)
- P300 (2)
- Schizophrenie (2)
- Serotonin (2)
- emotional regulation (2)
- 5-HT (1)
- 5-HT transporter (1)
- 5-HT1A (1)
- 5-HT2C (1)
- 5HT1A (1)
- 5HTT (1)
- Activation (1)
- Acute tryptophan depletion (1)
- Adult head (1)
- Alkoholismus (1)
- Alzheimer-Krankheit (1)
- Ankyrin (1)
- Anxiety (1)
- Anxiety-like behavior (1)
- Arbeitsgedächtnis (1)
- Assoziation (1)
- Auditory targets (1)
- BDNF (1)
- Beer-lambert law (1)
- Biomarker (1)
- Biomarkers (1)
- Bipolar disorder (1)
- Body weight (1)
- Brain (1)
- Catechol-0-Methyltransferase (1)
- Catecholmethyltransferase (1)
- Chronische Depression (1)
- Coexpression (1)
- DAT (1)
- DRD4 (1)
- Dementia (1)
- Dentalphobie (1)
- Disease progression (1)
- Disease-modifying therapies (1)
- Disorders (1)
- Dopamin (1)
- Drug development (1)
- Event related potentials (1)
- Expression (1)
- Extraversion (1)
- FPI-R (1)
- GAP (1)
- Gelelektrophorese (1)
- Gen-Umwelt-Interaktion (1)
- Human brain (1)
- I7 (1)
- Implizites Gedächtnis (1)
- Impulsivität (1)
- Insensitivity (1)
- Insulin Degrading Enzyme (1)
- Interferon-alpha (1)
- Jugendamt (1)
- Kindesmisshandlung (1)
- Knock-out mice (1)
- Latency (1)
- Lernstrategien (1)
- Lernstrategien bei Geschlecht Fach Semester (1)
- Long-term depression (1)
- Major depression (1)
- Media (1)
- Messenger-RNA (1)
- Model (1)
- Molecular-genetics (1)
- Molekulargenetik (1)
- Mood disorders (1)
- Mouse-brain (1)
- Münchhausen by proxy (1)
- Münchhausen-Syndrom der Angehörigen (1)
- Mütter (1)
- NIR-Spektroskopie (1)
- NIRS (1)
- NO-Synthetase (1)
- NPY (1)
- Neuronal plasticity (1)
- Neurons (1)
- Neuroprotection (1)
- PET-1 (1)
- Paarbindungsverhalten (1)
- Parkinson disease (1)
- Parkinson’s disease (1)
- Phobie (1)
- Photon migration (1)
- Physiological functions (1)
- Plasma Level (1)
- Polymerase-Kettenreaktion (1)
- Polytoxikomanie (1)
- Primärprävention (1)
- Propagation (1)
- Prosaccade (1)
- Präfrontaler Cortex (1)
- Prävention Prüfungsangst (1)
- Prüfungsangst (1)
- Rat-brain (1)
- Restraint stress (1)
- Saccadic eye-movements (1)
- Scattering (1)
- Schizophrenia (1)
- Senile Demenz (1)
- Serotonin transporter (1)
- Serotonin transporter polymorphism (1)
- Serotonin-Transporter-Polymorphism (1)
- Serotoninstoffwechsel (1)
- Sexualität (1)
- Sonic hedgehog (1)
- Spectroscopy fnirs (1)
- Spinnenphobie (1)
- Stickstoffoxidsynthase (1)
- Stimuli (1)
- Studienerfolg und Prüfungsangst (1)
- Surrogate endpoints (1)
- System (1)
- Task-performance (1)
- Tinnitus (1)
- Tissues (1)
- Transgenic mice (1)
- Transkranielle Magnetstimulation (1)
- Transporter (1)
- Triple in situ hybridization (1)
- VITA Studie (1)
- VITA study (1)
- Vasopressin (1)
- Vasopressin receptor gene (1)
- Vasopressinrezeptorgen (1)
- Vergence (1)
- Voluntary control (1)
- Zusammenhang Lernstrategien (1)
- Zykloide Psychose (1)
- acetylcholine (1)
- adulte ADHS (1)
- antidepressive agents (1)
- association studies (1)
- basal ganglia (1)
- behaviour (1)
- candidate gene (1)
- cycloid psychoses (1)
- dental phobia (1)
- dopamine (1)
- dopaminergics (1)
- electroencephalography (1)
- error-related negativity (1)
- evozierte Potentiale (1)
- facticious disorder (1)
- freezing (1)
- genetic risk factor (1)
- genetics (1)
- haplotypes (1)
- head (1)
- impulsivity (1)
- indans (1)
- iron (1)
- joint action (1)
- learning strategies (1)
- levodopa (1)
- life events (1)
- moclobemide (1)
- monoamine oxidase (1)
- monoamine oxidase inhibitors (1)
- mother (1)
- munchhausen by proxy (1)
- negative priming (1)
- negatives Priming (1)
- neuroimaging (1)
- nitric oxide synthase (1)
- object and spatial visual working memory (1)
- pair bonding (1)
- phenelzine (1)
- plasma levels (1)
- prefrontal cortex (1)
- prevention test anxiety (1)
- rTMS (1)
- rasagiline (1)
- reaction time (1)
- real-life interaction (1)
- research errors (1)
- selegiline (1)
- serotonin (1)
- simulation (1)
- social interaction (1)
- spider phobia (1)
- symptoms (1)
- test anxiety (1)
- tinnitus (1)
- tranylcypromine (1)
- verursachende Person (1)
- victims (1)
- visuell-bildliches Arbeitsgedächtnis (1)
- visuell-räumliches Arbeitsgedächtnis (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (30) (remove)
Neurophysiologische Evidenz für eine Störung des impliziten Gedächtnis bei Alkoholabhängigkeit
(2011)
Im Rahmen der vorliegenden Arbeit wurden 21 reine Alkoholpatienten, 6 polytoxikomane Alkoholpatienten und 18 gesunde Kontrollen neurophysiologisch untersucht. Basierend auf einem Paradigma zu Negativem Priming wurden Unterschiede zwischen den genannten Kollektiven bezüglich der Amplitude und Latenz der P300 im EEG untersucht. Kontrollpersonen zeigten in dieser Studie generell eine signifikant kürzere Latenz der P3a als beide Patientenkollektive, was als Hinweis auf eine kognitive Ineffizienz bei Alkoholpatienten gesehen werden kann. Darüber hinaus konnte gezeigt werden, dass reine Alkoholpatienten und polytoxikomane Alkoholpatienten bezüglich der Veränderungen der P300 getrennt betrachtet werden müssen, da sich signifikante Unterschiede bezüglich Latenz und Amplitude zwischen den beiden Patientenkollektiven zeigten. Ebenso gibt es Hinweise darauf, dass bei Studien zur P300 Geschlechterunterschiede berücksichtigt werden müssen. Mit vorliegender Studie konnte zudem die Theorie einer prominenten frontocentralen Verteilung der P3a unterstützt werden.
Dysfunktionen des serotonergen Neurotransmittersystems, innerhalb dessen die allelischen Variationen des 5-HTTLPR-Polymorphismus wiederum einen zentrale Rolle einnehmen, werden für die Genese verschiedener psychischer Erkrankungen diskutiert. Untersucht wurde die Interaktion zwischen der allelischen Variationen des 5-HTTLPR-Polymorphismus und Lebensereignissen, die mit Hilfe des Life History Calendar von Caspi bei 123 aADHS-Patienten erfasst wurden. Die Teilnehmer wurden über Lebenserfahrungen bis zu ihrem 21. Lebensjahr genau befragt, die so in additiver Wertung in den Life-Event-Effekt einflossen. Zudem wurden mit Hilfe der Persönlichkeitstests TPQ und NEO-PI-R Punktescores erhoben. Eine Marker*Life Event-Interaktion wurde nachgewiesen. Bei aAHDS-Patienten, die die homozygot lange Variante des 5-HTTLPR-Polymorphismus tragen, ist eine höhere Zahl an erlebten Life Events mit einem größerem Risiko assoziiert, eine Cluster-B-Persönlichkeitsstörung zu entwickeln. Eine geringere Anzahl an Life Events ist assoziiert mit einem geringerem Risiko für Persönlichkeitsstörungen.
Attention-deficit/hyperactivity disorder (ADHD) is a genetically complex childhood onset neurodevelopmental disorder which is highly persistent into adulthood. Several chromo-somal regions associated with this disorder were identified previously in genome-wide linkage scans, association (GWA) and copy number variation (CNV) studies. In this work the results of case-control and family-based association studies using a can-didate gene approach are presented. For this purpose, possible candidate genes for ADHD have been finemapped using mass array-based SNP genotyping. The genes KCNIP4, CDH13 and DIRAS2 have been found to be associated with ADHD and, in addition, with cluster B and cluster C personality disorders (PD) which are known to be related to ADHD. Most of the associations found in this work would not withstand correction for multiple testing. However, a replication in several independent populations has been achieved and in conjunction with previous evidence from linkage, GWA and CNV studies, it is assumed that there are true associations between those genes and ADHD. Further investigation of DIRAS2 by quantitative real-time PCR (qPCR) revealed expression in the hippocampus, cerebral cortex and cerebellum of the human brain and a significant increase in Diras2 expression in the mouse brain during early development. In situ hybrid-izations on murine brain slices confirmed the results gained by qPCR in the human brain. Moreover, Diras2 is expressed in the basolateral amygdala, structures of the olfactory system and several other brain regions which have been implicated in the psychopatholo-gy of ADHD. In conclusion, the results of this work provide further support to the existence of a strong genetic component in the pathophysiology of ADHD and related disorders. KCNIP4, CDH13 and DIRAS2 are promising candidates and need to be further examined to get more knowledge about the neurobiological basis of this common disease. This knowledge is essential for understanding the molecular mechanisms underlying the emergence of this disorder and for the development of new treatment strategies.
Prenatal stress (PS) has been shown to influence the development of the fetal brain and to increase the risk for the development of psychiatric disorders in later life. Furthermore, the variation of human serotonin transporter (5-HTT, SLC6A4) gene was suggested to exert a modulating effect on the association between early life stress and the risk for depression. In the present study, we used a 5-HttxPS paradigm to investigate whether the effects of PS are dependent on the 5-Htt genotype. For this purpose, the effects of PS on cognition, anxiety-and depression-related behavior were examined using a maternal restraint stress paradigm of PS in C57BL6 wild-type (WT) and heterozygous 5-Htt deficient (5-Htt +/-) mice. Additionally, in female offspring, a genome-wide hippocampal gene expression profiling was performed using the Affymetrix GeneChip (R) Mouse Genome 430 2.0 Array. 5-Htt +/- offspring showed enhanced memory performance and signs of reduced anxiety as compared to WT offspring. In contrast, exposure of 5-Htt +/- mice to PS was associated with increased depressive-like behavior, an effect that tended to be more pronounced in female offspring. Further, 5-Htt genotype, PS and their interaction differentially affected the expression of numerous genes and related pathways within the female hippocampus. Specifically, MAPK and neurotrophin signaling were regulated by both the 5-Htt +/- genotype and PS exposure, whereas cytokine and Wnt signaling were affected in a 5-Htt genotypexPS manner, indicating a genexenvironment interaction at the molecular level. In conclusion, our data suggest that although the 5-Htt +/- genotype shows clear adaptive capacity, 5-Htt +/- mice -particularly females-at the same time appear to be more vulnerable to developmental stress exposure when compared to WT offspring. Moreover, hippocampal gene expression profiles suggest that distinct molecular mechanisms mediate the behavioral effects of the 5-Htt genotype, PS exposure, and their interaction.
The transcription factor Lmx1b is essential for the differentiation and survival of central serotonergic (5-HTergic) neurons during embryonic development. However, the role of Lmx1b in adult 5-HTergic neurons is unknown. We used an inducible Cre-LoxP system to selectively inactivate Lmx1b expression in the raphe nuclei of adult mice. Pet1-CreER(T2) mice were generated and crossed with Lmx1b(flox/flox) mice to obtain Pet1-CreER(T2); Lmx1b(flox/flox) mice (which termed as Lmx1b iCKO). After administration of tamoxifen, the level of 5-HT in the brain of Lmx1b iCKO mice was reduced to 60% of that in control mice, and the expression of tryptophan hydroxylase 2 (Tph2), serotonin transporter (Sert) and vesicular monoamine transporter 2 (Vmat2) was greatly down-regulated. On the other hand, the expression of dopamine and norepinephrine as well as aromatic L-amino acid decarboxylase (Aadc) and Pet1 was unchanged. Our results reveal that Lmx1b is required for the biosynthesis of 5-HT in adult mouse brain, and it may be involved in maintaining normal functions of central 5-HTergic neurons by regulating the expression of Tph2, Sert and Vmat2.
Monoamine oxidase inhibitors (MAO-I) belong to the earliest drugs tried in Parkinson's disease (PD). They have been used with or without levodopa (L-DOPA). Non-selective MAO-I due to their side-effect/adverse reaction profile, like tranylcypromine have limited use in the treatment of depression in PD, while selective, reversible MAO-A inhibitors are recommended due to their easier clinical handling. For the treatment of akinesia and motor fluctuations selective irreversible MAO-B inhibitors selegiline and rasagiline are recommended. They are safe and well tolerated at the recommended daily doses. Their main differences are related to (1) metabolism, (2) interaction with CYP-enzymes and (3) quantitative properties at the molecular biological/genetic level. Rasagiline is more potent in clinical practise and has a hypothesis driven more favourable side effect/adverse reaction profile due to its metabolism to aminoindan. Both selegiline and rasagiline have a neuroprotective and neurorestaurative potential. A head-to head clinical trial would be of utmost interest from both the clinical outcome and a hypothesis-driven point of view. Selegiline is available as tablet and melting tablet for PD and as transdermal selegiline for depression, while rasagiline is marketed as tablet for PD. In general, the clinical use of MAO-I nowadays is underestimated. There should be more efforts to evaluate their clinical potency as antidepressants and antidementive drugs in addition to the final proof of their disease-modifying potential. In line with this are recent innovative developments of MAO-I plus inhibition of acetylcholine esterase for Alzheimer's disease as well as combined MAO-I and iron chelation for PD.
Background:
Antidepressant drugs (ADs) have been shown to activate BDNF (brain-derived neurotrophic factor) receptor TrkB in the rodent brain but the mechanism underlying this phenomenon remains unclear. ADs act as monoamine reuptake inhibitors and after prolonged treatments regulate brain bdnf mRNA levels indicating that monoamine-BDNF signaling regulate AD-induced TrkB activation in vivo. However, recent findings demonstrate that Trk receptors can be transactivated independently of their neurotrophin ligands.
Methodology:
In this study we examined the role of BDNF, TrkB kinase activity and monoamine reuptake in the AD-induced TrkB activation in vivo and in vitro by employing several transgenic mouse models, cultured neurons and TrkB-expressing cell lines.
Principal Findings:
Using a chemical-genetic TrkB(F616A) mutant and TrkB overexpressing mice, we demonstrate that ADs specifically activate both the maturely and immaturely glycosylated forms of TrkB receptors in the brain in a TrkB kinase dependent manner. However, the tricyclic AD imipramine readily induced the phosphorylation of TrkB receptors in conditional bdnf(-/-) knock-out mice (132.4+/-8.5% of control; P = 0.01), indicating that BDNF is not required for the TrkB activation. Moreover, using serotonin transporter (SERT) deficient mice and chemical lesions of monoaminergic neurons we show that neither a functional SERT nor monoamines are required for the TrkB phosphorylation response induced by the serotonin selective reuptake inhibitors fluoxetine or citalopram, or norepinephrine selective reuptake inhibitor reboxetine. However, neither ADs nor monoamine transmitters activated TrkB in cultured neurons or cell lines expressing TrkB receptors, arguing that ADs do not directly bind to TrkB.
Conclusions:
The present findings suggest that ADs transactivate brain TrkB receptors independently of BDNF and monoamine reuptake blockade and emphasize the need of an intact tissue context for the ability of ADs to induce TrkB activity in brain.
In der vorliegenden Arbeit sollte anhand der error-related negativity (ERN) eine eingeschränkte Fehlerwahrnehmung und im weiteren Sinne eine eingeschränkte Handlungskontrolle bei Patienten mit Erkrankungn aus dem schizophrenen Formenkreis im Vergleich zu gesunden Probanden dargestellt werden. Für diesen Vergleich wurde zusätzlich die error- positivity (Pe) herangezogen. Anhand dieser Parameter erfolgte zusätzlich ein Vergleich der Patienten mit einer klassischen Schizophrenie und solchen mit einer Zykloiden Psychose mit Blick auf die bereits existierende klinische Differenzierung gemäß Leonhard. Als Ergebnis ließen sich im Vergleich zu den Kontrollprobanden eine eingeschränkte ERN und eine eingeschränkte Pe bei beiden Patientengruppen feststellen. Die Hypothese, dass Patienten mit einer Zykloiden Psychose sich nicht nur klinisch, sondern auch elektrophysiologisch von den Patienten mit einer klassischen Schizophrenie unterscheiden, ließ sich anhand der ERN und der Pe nicht untermauern. Anders als angenommen wiesen die Patienten mit einer Zykloiden Psychose keine weniger starke Einschränkung der beiden elektrophysiologischen Parameter auf.
In dieser Arbeit wurde mit Hilfe der Ergebnisse der Basisuntersuchung der VITA-Studie untersucht, ob der Längenpolymorphismus des Serotonin Transporters einen Einfluss auf die Entstehung einer Depression im Alter oder einer Demenz hat. Die Ergebnisse zeigten, dass eine Assoziation zwischen dem 5-HTTLPR und einer Depression besteht. Ein Zusammenhang zwischen dem 5-HTTLPR und einer Demenzerkrankung konnte jedoch nicht nachgewiesen werden.
Erhebung erster Daten über das Vorliegen des Münchhausen-by-proxy-Syndroms, einer besonderen Form der Kindesmisshandlung, in Deutschland. Alle Kinderkliniken in Deutschland wurden im ersten Schritt nach Fällen und dem überblickten Zeitraum gefragt. Im zweiten Schritt folgte ein 23-seitiger Fragebogen mit Angaben u.a. zum Opfer, zu vorliegenden oder geschilderten Symptomen, zur Art des Missbrauchsnachweises, zur verursachenden Person, zum Verhalten der verursachenden Person, zum Partner der verursachenden Person, zu Geschwisterkindern, zu rechtlichen Folgen für die Opfer und die verursachende Person. Dem geschichtlichen Abspann folgte nach Auswertung unserer Daten eine Diskussion im Hinblick auf die derzeitige internationale Datenlage sowie ein Blick in die Zukunft.